Lysophosphatidic acid (LPA), abundantly released by ovarian cancer cells, is known to contribute to ovarian cancer aggressiveness by stimulating the synthesis of IL-6 and of VEGF[78,79], among others. This evidence concerns the gene IL6 and ovarian carcinoma.